Cadmium as a possible cause of bladder cancer: a review of accumulated evidence

Environmental Science and Pollution Research

Volumn 21, Issue 18, 2014, Pages 10561-10573

  Feki Tounsi, Molka ^a,b   Hamza Chaffai, Amel ^a  

^a University of Sfax   (Tunisia)

^b CENTRE DE BIOTECHNOLOGIE DE SFAX   (Tunisia)

Author keywords

Bladder cancer risk; Cadmium exposure; Toxicity; Urinary tract

Indexed keywords

CADMIUM; CANCER; CARCINOGEN; HEALTH RISK; LITERATURE REVIEW; POLLUTION EXPOSURE; TEMPORAL ANALYSIS; TOXICITY;

CADMIUM;

ANIMAL; BLADDER TUMOR; CHEMICALLY INDUCED; HUMAN; METABOLISM; OCCUPATIONAL EXPOSURE;

ANIMALS; CADMIUM; HUMANS; OCCUPATIONAL EXPOSURE; URINARY BLADDER NEOPLASMS;

EID: 84907860998     PISSN: 09441344     EISSN: 16147499     Source Type: Journal    
DOI: 10.1007/s11356-014-2970-0     Document Type: Article

References (148)

1. Aaboe M, Marcussen N, Jensen KM, Thykjaer T, Dyrskjøt L, Orntoft TF (2005) Gene expression profiling of noninvasive primary urothelial tumours using microarrays. Br J Cancer 93(10):1182–1190
2. Abshire MK, Devor DE, Diwan BA, Shaughnessy JD Jr, Waalkes MP (1996) In vitro exposure to cadmium in rat L6 myoblasts can result in both enhancement and suppression of malignant progression in vivo. Carcinogenesis 17:1349–1356
3. Adams SV, Newcomb PA, Shafer MM, Atkinson C, Bowles EJ, Newton KM, Lampe JW (2011) Sources of cadmium exposure among healthy premenopausal women. Sci Total Environ 409(9):1632–1637. doi:10.1016/j.scitotenv.2011.01.037
4. Aimola P, Carmignani M, Volpe AR, Di Benedetto A, Claudio L, Waalkes MP, van Bokhoven A, Tokar EJ, Claudio PP (2012) Cadmium induces p53-dependent apoptosis in human prostate epithelial cells. PLoS One 7(3):e33647
5. Akesson A, Lundh T, Vahter M, Bjellerup P, Lidfeldt J, Nerbrand C, Samsioe G, Strömberg U, Skerfving S (2005) Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ Health Perspect 113:1627–1631
6. Alam J, Wicks C, Stewart D, Gong P, Touchard C, Otterbein S, Choi AM, Burow ME, Tou J (2000) Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. Role of p38 kinase and Nrf2 transcription factor. J Biol Chem 275:27694–27702
7. Alvarez SM, Gomez NN, Scardapane L, Zirulnik F, Martinez D, Gimenez MS (2004) Morphological changes and oxidative stress in rat prostate exposed to a non-carcinogenic dose of cadmium. Toxicol Lett 153:365–376
8. Amaral AF, Cymbron T, Gärtner F, Lima M, Rodrigues AS (2009) Trace metals and over-expression of metallothioneins in bladder tumoral lesions: a case-control study. BMC Vet Res 18:5–24
9. Anderson B, Naish W (2008) Bladder cancer and smoking. Part 1: addressing the associated risk factors. Br J Nurs 17(18):1182–1186
10. Andrews GK (2000) Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem Pharmacol 59:95–104
11. Antila E, Mussalo-Rauhamaa H, Kantola M, Atroshi F, Westermarck T (1996) Association of cadmium with human breast cancer. Sci Tot Environ 186:251–256
12. Arita A, Costa M (2009) Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium. Metallomics 1(3):222–228
13. ATSDR (1999) Toxicological profile of cadmium. Agency for Toxic Substances and Disease Registry
14. Badisa VL, Latinwo LM, Odewumi CO, Ikediobi CO, Badisa RB, Brooks-Walter A, Lambert AT, Nwoga J (2008) Cytotoxicity and stress gene microarray analysis in cadmium-exposed CRL-1439 normal rat liver cells. Int J Mol Med 22:213–219
15. Benbrahim-Tallaa L, Liu J, Webber MM, Waalkes MP (2007a) Estrogen signaling and disruption of androgen metabolism in acquired androgen-independence during cadmium carcinogenesis in human prostate epithelial cells. Prostate 67:135–145
16. Benbrahim-Tallaa L, Waterland RA, Dill AL, Webber MM, Waalkes MP (2007b) Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase. Environ Health Perspect 115:1454–1459
17. Bernard A (2008) Cadmium and its adverse effects on human health. Indian J Med Res 128(4):557–64
18. Bernard A, Lauwerys R (1986) Effects of cadmium exposure in humans. In: Foulkes EC (ed) Handbook of experimental pharmacology. Springer, Berlin, pp 135–177
19. Blumenthal NC, Cosma V, Skyler D, LeGeros J, Walters M (1995) The effect of cadmium on the formation and properties of hydroxyapatite in vitro and its relation to cadmium toxicity in the skeletal system. Calcif Tissue Int 56:316322
20. Boffetta P (2008) Tobacco smoking and risk of bladder cancer. Scand J Urol Nephrol Suppl. (218):45-54. doi:10.1080/03008880802283664
21. Bonda E, Wlostowski T, Krasowska A (2004) Testicular toxicity induced by dietary cadmium is associated with decreased testicular zinc and increased hepatic and renal metallothionein and zinc in the bank vole (Clethrionomys glareolus). BioMetals 17:615–624
22. Bradshaw AD (2012) Diverse biological functions of the SPARC family of proteins. Int J Biochem Cell Biol 44(3):480–488. doi:10.1016/j.biocel.2011.12.021
23. Brennan P, Bogillot O, Cordier S, Greiser E, Schill W, Vineis P, Lopez-Abente G, Tzonou A, Chang-Claude J, Bolm-Audorff U, Jöckel KH, Donato F, Serra C, Wahrendorf J, Hours M, T’Mannetje A, Kogevinas M, Boffetta P (2000) Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer 86(2):289–94
24. Chen J, Wang M, Xi B, Xue J, He D, Zhang J, Zhao Y (2012) SPARC is a key regulator of proliferation, apoptosis and invasion in human ovarian cancer. PLoS One 7(8):e42413
25. Christian BJ, Loretz LJ, Oberley TD, Reznikoff CA (1987) Characterization of human uroepithelial cells immortalized in vitro by simian virus 40. Cancer Res 47(22):6066–6073
26. Chun YS, Choi E, Kim GT, Choi H, Kim CH, Lee MJ, Kim MS, Park JW (2000) Cadmium blocks hypoxiainducible factor (HIF)-1-mediated response to hypoxia by stimulating the proteasome-dependent degradation of HIF-1alpha. Eur J Biochem 267:4198–204
27. Cohen SM (1998) Cell proliferation and carcinogenesis. Drug Metab Rev 30:339–357
28. Cohen SM, Lawson TA (1995) Rodent bladder tumors do not always predict for humans. Cancer Lett 93:9–16
29. Council EC (1998) Directive 98/83/EC of 3 November 1998 on the quality of water intended for human consumption. Off J L330:32–54
30. Crallan RA, Lord PG, Rees RW, Southgate J (2002) Inter-individual variation in urothelial DNA repair gene expression in vitro. Toxicol In Vitro 16:383–387
31. Dally H, Hartwig A (1997) Induction and repair inhibition of oxidative DNA damage by nickel(II) and cadmium(II) in mammalian cells. Carcinogenesis 18:1021–6
32. Darewicz G, Malczyk E, Darewicz J (1998) Investigations of urinary cadmium content in patients with urinary bladder carcinoma. Int Urol Nephrol 30:137–139
33. Diggle CP, Pitt E, Harnden P, Trejdosiewicz LK, Southgate J (2001) Role of p53 in the responses of human urothelial cells to genotoxic damage. Int J Cancer 93:199–203
34. Elinder CG, Kjellstrom T (1986) Carcinogenic and mutagenic effects. In: Friberg L, Elinder CG, Kjellstrom T, Nordberg GF (eds) Cadmium and Health: a toxicological and epidemiological appraisal, vol 1. CRC, Boca Raton, pp 205–229
35. Eriksson J, Stenberg B, Andersson A, Andersson R (2000) The current status of Swedish arable soils and cereal crops, report vol. 5062, Swedish Environmental Protection Agency, Solna, Sweden
36. Fassina AS, Calliari I, Sangiorgio A, Rossato M, Ramigni M, Dal Bianco M, Pagano F (1990) Quantitative analysis of trace elements in human clear cell carcinoma of the kidney by energy-dispersive X-ray fluorescence. Eur Urol 18:140–144
37. Feki-Tounsi M, Olmedo P, Gil F, Khlifi R, Mhiri MN, Rebai A, Hamza-Chaffai A (2013) Cadmium in blood of Tunisian men and risk of bladder cancer: interactions with arsenic exposure and smoking. Environ Sci Pollut Res Int. doi:10.1007/s11356-013-1716-8
38. Feustel A, Wennrich R (1986) Zinc and cadmium plasma and erythrocyte levels in prostatic carcinoma, BPH, urological malignancies, and inflammations. Prostate 8(1):75–9
39. Freedman ND, Silverman DT, Hollenbeck AR, Schatzkin A, Abnet CC (2011) Association between smoking and risk of bladder cancer among men and women. JAMA 306(7):737–45. doi:10.1001/jama.2011.1142
40. Friberg L (1984) Cadmium and the kidney. Environ Health Perspect 54:1–11
41. Friedman LS, Lukyanova EM, Kundiev Y, Shkiryak-Nizhnyk ZA, Chislovska NV, Mucha A, Zvinchuk AV, Oliynyk I, Hryhorczuk D (2006) Anthropometric, environmental, and dietary predictors of elevated blood cadmium levels in Ukrainian children: Ukraine ELSPAC group. Environ Res 102:83–89
42. Galal-Gorchev H (1993) Dietary intake, levels in food and estimated intake of lead, cadmium and mercury. Food Addit Contam 10:115–28
43. Garrett SH, Park S, Sens MA, Somji S, Singh RK, Namburi VBRK, Sens DA (2005) Expression of metallothionein isoform 3 is restricted at the post-transcriptional level in human bladder epithelial cells. Toxicol Sci 87:66–74
44. Goering PL, Waalkes MP, Klaassen CD (1994) Toxicology of Cadmium. In: Goyer RA, MG C (eds) Handbook of experimental pharmacology: toxicology of metals, biochemical effects, vol 115. Springer, New York, pp 189–214
45. Goodman JI, Watson RE (2002) Altered DNA methylation: a secondary mechanism involved in carcinogenesis. Annu Rev Pharmacol Toxicol 42:501–525
46. Goyer RA, Liu J, Waalkes MP (2004) Cadmium and cancer of prostate and testis. Biometals 5:555–558
47. Hahn WC, Weinberg RA (2002) Modeling the molecular circuitry of cancer. Nat Rev Cancer 2:331–341
48. Hamer DH (1986) Metallothionein. Annu Rev Biochem 55:913–951
49. Hartwig A (2012) Metal interaction with redox regulation: an integrating concept in metal carcinogenesis? Free Radic. Biol Med 55C:63–72. doi:10.1016/j.freeradbiomed.2012.11.009
50. Hartwig A, Schwerdtle T (2002) Interactions by carcinogenic metal compounds with DNA repair processes: toxicological implications. Toxicol Lett 127:47–54
51. Hechtenberg S, Schafer T, Benters J, Beyersmann D (1996) Effects of cadmium on cellular calcium and proto-oncogene expression. Ann Clin Lab Sci 26:512–521
52. Hellstrom L, Elinder CG, Dahlberg B, Lundberg M, Järup L, Persson B, Axelson O (2001) Cadmium exposure and end-stage renal disease. Am J Kidney Dis 38:1001–1008
53. Heney NM (1992) Natural history of superficial bladder cancer. Prognostic features and long-term disease course. Urol Clin North Am 19:429–433
54. Hu J, Mao Y, White K (2002) Canadian Cancer Registries Epidemiology Research Group. Renal cell carcinoma and occupational exposure in Canada. Occup Med 52:157–164
55. Huang D, Zhang Y, Qi Y, Chen C, Ji W (2008) Global DNA hypomethylation, rather than reactive oxygen species (ROS), a potential facilitator of cadmium-stimulated K562 cell proliferation. Toxicol Lett 179:43–47
56. Huff J, Lunn RM, Waalkes MP, Tomatis L, Infante PF (2007) Cadmium-induced cancers in animals and in humans. Int J Occup Environ Health 13(2):202–212
57. Inglot P, Lewinska A, Potocki L, Oklejewicz B, Tabecka-Lonczynska A, Koziorowski M, Bugno-Poniewierska M, Bartosz G, Wnuk M (2012) Cadmium-induced changes in genomic DNA-methylation status increase aneuploidy events in a pig Robertsonian translocation model. Mutat Res 747(2):182–189. doi:10.1016/j.mrgentox.2012.05.007
58. International Agency for Research on Cancer (IARC) (1993) IARC monographs on the evaluation of the carcinogenic risk to man: beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. Working group views and expert opinions. IARC, Lyon
59. Järup L (2002) Cadmium overload and toxicity. Nephrol Dial Transplant 17(2):35–39
60. Järup L, Akesson A (2009) Current status of cadmium as an environmental health problem. Toxicol Appl Pharmacol 238(3):201–8. doi:10.1016/j.taap.2009.04.020
61. Järup L, Berglund M, Elinder CG, Nordberg G, Vahter M (1998) Health effects of cadmium exposure—a review of the literature and a risk estimate. Scand J Work Environ Health 24(1):1–51
62. Jemal A, Siegel R, Ward E (2007) Cancer statistics, 2007. CA Cancer J Clin 57:43–66
63. Jeong EM, Moon CH, Kim CS, Lee SH, Baik EJ, Moon CK, Jung YS (2004) Cadmium stimulates the expression of ICAM-1 via NF-kappaB activation in cerebrovascular endothelial cells. Biochem Biophys Res Commun 320:887–892
64. Jiang J, Ulbright TM, Younger C, Sanchez K, Bostwick DG, Koch MO, Eble JN, Cheng L (2001) Cytokeratin 7 and cytokeratin 20 in primary urinary bladder carcinoma and matched lymph node metastasis. Arch Pathol Lab Med 125(7):921–923
65. Jin P, Ringertz NR (1990) Cadmium induces transcription of proto-oncogenes c-jun and c-myc in rat L6 myoblasts. J Biol Chem 265:14061–14064
66. Jin T, Lu J, Nordberg M (1998) Toxicokinetics and biochemistry of cadmium with special emphasis on the role of metallothionein. Neurotoxicology 19:529–535
67. Johri N, Jacquillet G, Unwin R (2010) Heavy metal poisoning: the effects of cadmium on the kidney. Biometals 23(5):783–792
68. Joseph P (2009) Mechanisms of cadmium carcinogenesis. Toxicol Appl Pharmacol 238(3):272–279
69. Joseph P, Lei YX, Whong WZ, Ong TM (2002) Oncogenic potential of mouse translation elongation factor-1 delta, a novel cadmium-responsive proto-oncogene. J Biol Chem 277:6131–6136
70. Joseph P, Lei YX, Ong TM (2004) Up-regulation of expression of translation factors-a novel molecular mechanism for cadmium carcinogenesis. Mol Cell Biochem 255:93–101
71. Kao C, Wu SQ, Bhatthacharya M, Meisner LF, Reznikoff CA (1992) Losses of 3p, 11p, and 13q in EJ/ras-transformable simian virus 40-immortalized human uroepithelial cells. Genes Chromosomes Cancer 4:158–168
72. Kellen E, Zeegers MP, Hond ED, Buntinx F (2007) Blood cadmium may be associated with bladder carcinogenesis: the Belgian case-control study on bladder cancer. Cancer Detect Prev 31(1):77–82
73. Kjellstrom T (1986) Renal effects. In: Friberg L, Elinder CG, Kjellstrom T, Nordberg GF (eds) Cadmium and health: a toxicological and epidemiological appraisal, vol 2. CRC, Boca Raton, pp 21–109
74. Klaassen CD, Liu J (1998) Metallothionein transgenic and knock-out mouse models in the study of cadmium toxicity. J Toxicol Scie 23(2):97–102
75. Klaassen CD, Liu J, Choudhuri S (1999) Metallothionein: an intracellular protein to protect against cadmium toxicity. Annu Rev Pharmacol Toxicol 39:267–294
76. Kogevinas M, Trichopoulos D (2002) Urinary bladder cancer. In: Adami HO, Hunter DJ, Trichopoulos D (eds) Textbook of cancer epidemiology. Oxford University Press, New York, pp 446–466
77. Koyuturk M, Yanardag R, Bolkent S, Tunali S (2007) The potential role of combined anti-oxidants against cadmium toxicity on liver of rats. Toxicol Ind Health 23:393–401
78. Kyriazis AA, Kyriazis AP, McCombs WB 3rd, Peterson WD Jr (1984) Morphological, biological, and biochemical characteristics of human bladder transitional cell carcinomas grown in tissue culture and in nude mice. Cancer Res 44(9):3997–4005
79. Larson J, Yasmin T, Sens DA, Zhou XD, Sens MA, Garrett SH, Dunlevy JR, Cao L, Somji S (2010) SPARC gene expression is repressed in human urothelial cells (UROtsa) exposed to or malignantly transformed by cadmium or arsenite. Toxicol Lett 199(2):166–172
80. Lee MJ, Nishio H, Ayaki H, Yamamoto M, Sumino K (2002) Upregulation of stress response mRNAs in COS-7 cells exposed to cadmium. Toxicology 174:109–117
81. Letašiová S, Medve’ová A, Šovčíková A, Dušinská M, Volkovová K, Mosoiu C, Bartonová A (2012) Bladder cancer, a review of the environmental risk factors. Environ Health., 11 Suppl 1:S11. doi: 10.1186/1476-069X-11-S1-S11
82. López-Alonso M, Miranda M, García-Partida P, Cantero F, Hernández J, Benedito JL (2007) Use of dogs as indicators of metal exposure in rural and urban habitats in NW Spain. Sci Total Environ 372(2–3):668–75
83. Martinez-Zamudio R, Ha HC (2011) Environmental epigenetics in metal exposure. Epigenetics 6(7):820–827
84. Matsuno K, Kodama Y, Tsuchiya K (1991) Biological half-time and body burden of cadmium indogs after a long-term oral administration of cadmium. Biol Trace Elem Res 29(2):111–23
85. McLaughlin MJ (2001) Bioavailability of metals to terrestrial plants. In: Allen HE (ed) Bioavailability of metals in terrestial ecosystems. Importance of partitioning for bioavailability to invertebrates, microbes and plants. SETAC Press, Pensacola, FL, pp 39–68
86. McMurray CT, Tainer JA (2003) Cancer, cadmium and genome integrity. Nat Genet 34:239–241
87. Mensing TT, Speijers GJ, Meulenbelt J (2003) Health implications of exposure to environmental nitrogenous compounds. Toxicol Rev 22(1):41–51
88. Min KS, Ueda H, Tanaka K (2008) Involvement of intestinal calcium transporter 1 and metallothionein in cadmium accumulation in the liver and kidney of mice fed a low-calcium diet. Toxicol Lett 176(1):85–92
89. Minami A, Takeda A, Nishibaba D, Takefuta S, Oku N (2001) Cadmium toxicity in synaptic neurotransmission in the brain. Brain Res 894:336–339
90. Misra RR, Crance KA, Bare RM, Waalkes MP (1997) Lack of correlation between the inducibility of metallothionein mRNA and metallothionein protein in cadmium-exposed rodents. Toxicology 117:99–109
91. Misra UK, Gawdi G, Akabani G, Pizzo SV (2002) Cadmium induced DNA synthesis and cell proliferation in macrophages: the role of intracellular calcium and signal transduction mechanisms. Cell Signal 14:327–340
92. Misra UK, Gawdi G, Pizzo SV (2003) Induction of mitogenic signalling in the 1LN prostate cell line on exposure to submicromolar concentrations of cadmium. Cell Signal 15:1059–1070
93. Moll R, Divo M, Langbein L (2008) The human keratins: biology and pathology. Histochem Cell Biol 129(6):705–733
94. Morselt AF (1991) Environmental pollutants and diseases. A cell biological approach using chronic cadmium exposure in the animal model as a paradigm case. Toxicology 70:1–132
95. National Toxicology Program (2000) Tenth report on carcinogenesis. Department of Health and Human Health Services. Research Triangle Park NC. III-42-III-44
96. Nordberg GF (2009) Historical perspectives on cadmium toxicology. Toxicol Appl Pharmacol 238(3):192–200. doi:10.1016/j.taap.2009.03.015
97. Nordberg G, Nogawa K, Nordberg M, Friberg L (2007) Cadmium. In: Nordberg G, Fowler B, Nordberg M, Friberg L (eds) Handbook on the toxicology of metals. Academic, New York, pp 65–78
98. Olsson IM, Eriksson J, Öborn I, Skerfving S, Oskarsson A (2005) Cadmium in food production systems—a health risk for sensitive population groups. Ambio 34:344–351
99. Othumpangat S, Kashon M, Joseph P (2005) Eukaryotic translation initiation factor 4E is a cellular target for toxicity and death due to exposure to cadmium chloride. J Biol Chem 280:25162–25169
100. Parkin DM (2008) The global burden of urinary bladder cancer. Scand J Urol Nephrol Suppl. doi:10.1080/03008880802285032
101. Pesch B, Haerting J, Ranft U, Klimpel A, Oelschlagel B, Schill W (2000) MURC Study Group. Occupational risk factors for renal cell carcinoma: agent-specific results from a case–control study in Germany. Int J Epidemiol 29, 1014–1024
102. Petzoldt L, Leigh IM, Duffy PG, Sexton C, Masters RW (1995) Immortalization of human urothelial cells. Urol Res 23:377–380
103. Podhajcer OL, Benedetti L, Girotti MR, Prada F, Salvatierra E, Llera AS (2008) The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host. Cancer Metastasis Rev 27(3):523–537. doi:10.1007/s10555-008-9135-x
104. Poirier LA, Vlasova TI (2002) The prospective role of abnormal methyl metabolism in cadmium toxicity. Environ Health Perspect 110(5):793–795
105. Poirier MC, Fullerton NF, Smith BA, Beland FA (1995) DNA adduct formation and tumorigenesis in mice during the chronic administration of 4-aminobiphenyl at multiple dose levels. Carcinogenesis 16:2917–2921
106. RTI (Research Triangle Institute) and ATSDR (Agency for Toxic Substances and Disease Registry) (1999) Toxicological profile for cadmium. U.S. Dept. of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, Atlanta, GA
107. Satarug S (2012) Long-term exposure to cadmium in food and cigarette smoke, liver effects and hepatocellular carcinoma. Curr Drug Metab 13:257–71
108. Satarug S, Moore MR (2004) Adverse health effects of chronic exposure to low-level cadmium in foodstuffs and cigarette smoke. Environ Health Perspect 112:1099–1103
109. Schwartz GG, Reis IM (2000) Is cadmium a cause of human pancreatic cancer? Cancer Epidemiol Biomarkers Prev 9:139–145
110. Sens MA, Somji S, Lamm DL, Garrett SH, Slovinsky F, Todd JH, Sens DA (2000) Metallothionein isoform 3 as a potential biomarker for human bladder cancer. Environ Health Perspect 108(5):413–418
111. Sens DA, Park S, Gurel V, Sens MA, Garrett SH, Somji S (2004) Inorganic cadmium- and arsenite-induced malignant transformation of human bladder urothelial cells. Toxicol Sci 79:56–63
112. Shetty S, Gokul S (2012) Keratinization and its disorders. Oman Med J 27(5):348–357. doi:10.5001/omj.2012.90
113. Siemiatycki J, Dewar R, Nadon L, Gérin M (1994) Occupational risk factors for bladder cancer: results from a case-control study in Montreal, Quebec, Canada. Am J Epidemiol 140:1061–1080
114. Somji S, Sens MA, Lamm DL, Garrett SH, Sens DA (2001) Metallothionein isoform 1 and 2 gene expression in the human bladder: evidence for upregulation of MT-1X mRNA in bladder cancer. Cancer Detect Prev 25(1):62–75
115. Somji S, Bathula CS, Zhou XD, Sens MA, Sens DA, Garrett SH (2008) Transformation of human urothelial cells (UROtsa) by as and cadmium induces the expression of keratin 6a. Environ Health Perspect 116(4):434–440
116. Somji S, Zhou XD, Mehus A, Sens MA, Garrett SH, Lutz KL, Dunlevy JR, Zheng Y, Sens DA (2010) Variation of keratin 7 expression and other phenotypic characteristics of independent isolates of cadmium transformed human urothelial cells (UROtsa). Chem Res Toxicol 23(2):348–356
117. Somji S, Cao L, Mehus A, Zhou XD, Sens MA, Dunlevy JR, Garrett SH, Zheng Y, Larson JL, Sens DA (2011) Comparison of expression patterns of keratin 6, 7, 16, 17, and 19 within multiple independent isolates of As(+3)- and Cd (+2)-induced bladder cancer: keratin 6, 7, 16, 17, and 19 in bladder cancer. Cell Biol Toxicol 27:381–396
118. Takiguchi M, Achanzar WE, Qu W, Li G, Waalkes MP (2003) Effects of cadmium on DNA-(cytosine-5) methyltransferase activity and DNA methylation status during cadmium-induced cellular transformation. Exp Cell Res 286(2):355–365
119. Talaska G, Dooley KL, Kadlubar FF (1990) Detection and characterization of carcinogen-DNA adducts in exfoliated urothelial cells from 4-aminobiphenyl-treated dogs by 32P-postlabelling and subsequent thin-layer and high-pressure liquid chromatography. Carcinogenesis 11:639–646
120. Tao L, Yang S, Xie M, Kramer PM, Pereira MA (2000) Hypomethylation and overexpression of c-jun and c-myc protooncogenes and increased DNA methyltransferase activity in dichloroacetic and trichloroacetic acid-promoted mouse tumors. Cancer Lett 158:185–193
121. Thévenod F (2009) Cadmium and cellular signaling cascades: to be or not to be? Toxicol Appl Pharmacol 238(3):221–239
122. Thevenod F, Friedmann JM, Katsen AD, Hauser IA (2000) Up-regulation of multidrug resistance P-glycoprotein via nuclear factor-kappaB activation protects kidney proximal tubule cells from cadmium- and reactive oxygen species-induced apoptosis. J Biol Chem 275:1887–1896
123. Tomza-Marciniak A, Pilarczyk B, Bąkowska M, Ligocki M, Gaik M (2012) Lead, cadmium and other metals in serum of pet dogs from an urban area of NW Poland. Biol Trace Elem Res 149(3):345–51. doi:10.1007/s12011-012-9433-6
124. Trzcinka-Ochocka M, Jakubowski M, Szymczak W, Janasik B, Brodzka R (2010) The effects of low environmental cadmium exposure on bone density. Environ Res 110(3):286–293. doi:10.1016/j.envres.2009.12.003
125. Vesey DA (2010) Transport pathways for cadmium in the intestine and kidney proximal tubule: focus on the interaction with essential metals. Toxicol Lett 198(1):13–19. doi:10.1016/j.toxlet.2010.05.004
126. Villanueva CM, Cantor KP, Grimalt JO, Malats N, Silverman D, Tardon A, Garcia-Closas R, Serra C, Carrato A, Castaño-Vinyals G, Marcos R, Rothman N, Real FX, Dosemeci M, Kogevinas M (2007) Bladder cancer and exposure to water disinfection by-products through ingestion, bathing, showering, and swimming in pools. Am J Epidemiol 165(2):148–56
127. Vinceti M, Venturelli M, Sighinolfi C, Trerotoli P, Bonvicini F, Ferrari A, Bianchi G, Serio G, Bergomi M, Vivoloi G (2007) Case-control study of toenail cadmium and prostate cancer risk in Italy. Sci Tot Env 373(1):77–78
128. von Zglinicki T, Edwall C, Ostlund E, Lind B, Nordberg M, Ringertz NR, Wroblewski J (1992) Very low cadmium concentrations stimulate DNA synthesis and cell growth. J Cell Sci 103:1073–1081
129. Waalkes MP (2000) Cadmium carcinogenesis. J Inorg Biochem 79:241–244
130. Waalkes MP (2003) Cadmium carcinogenesis. Mutat Res 533(1–2):107–120
131. Waalkes MP, Rehm S (1994) Cadmium and prostate cancer. J Toxicol Environ Health 43:251–269
132. Waalkes MP, Perantoni A, Rehm S (1989a) Tissue susceptibility factors in cadmium carcinogenesis. Correlation between cadmium-induction of prostatic tumors in rats and an apparent deficiency of metallothionein. Biol Trace Elem Res 21:483–90
133. Waalkes MP, Rehm S, Riggs CW, Bare RM, Devor DE, Poirier LA, Wenk ML, Henneman JR (1989b) Cadmium carcinogenesis in male Wistar [Crl:(WI)BR] rats: dose-response analysis of effects of zinc on tumor induction in the prostate, in the testes, and at the injection site. Cancer Res 49:4282–4288
134. Waalkes MP, Rehm S, Perantoni AO, Coogan TP (1992) Cadmium exposure in rats and tumours of the prostate. IARC Sci Publ (118):391–400
135. Waalkes MP, Rehm S, Coogan TP, Ward JM (1997) Role of cadmium in the etiology of cancer of the prostate. In: Thomas JA, Colby HD (eds) Endocrine toxicology, 2nd edn. Taylor and Francis, Washington, DC, pp 227–243
136. Waalkes MP, Anver M, Diwan BA (1999a) Carcinogenic effects of cadmium in the noble (NBL/Cr) rat: induction of pituitary, testicular, and injection site tumors and intraepithelial proliferative lesions of the dorsolateral prostate. Toxicol Sci 52:154–161
137. Waalkes MP, Anver MR, Diwan BA (1999b) Chronic toxic and carcinogenic effects of oral cadmium in the Noble (NBL/Cr) rat: induction of neoplastic and proliferative lesions of the adrenal, kidney, prostate, and testes. J Toxicol Environ Health 58:199–214
138. Waalkes MP, Rehm S, Cherian MG (2000) Repeated cadmium exposures enhance the malignant progression of ensuing tumors in rats. Toxicol Sci 54:110–120
139. Waisberg M, Joseph P, Hale B, Beyersmann D (2003) Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology 192:95–117
140. Wang CY, Yamada H, Morton KC, Zukowski K, Lee MS, King CM (1988) Induction of repair synthesis of DNA in mammary and urinary bladder epithelial cells by N-hydroxy derivatives of carcinogenic arylamines. Cancer Res 48:4227–4232
141. Wang HY, Li YY, Shao Q, Hou JH, Wang F, Cai MB, Zeng YX, Shao JY (2012) Secreted protein acidic and rich in cysteine (SPARC) is associated with nasopharyngeal carcinoma metastasis and poor prognosis. J Transl Med 10:27
142. Webster LR, McKenzie GH, Moriarty HT (2002) Organophosphate based pesticides and genetic damage implicated in bladder cancer. Cancer Genet Cytogenet 133(2):112–117
143. West RW, Sheldon WG, Gaylor DW, Haskin MG, Delongchamp RR, Kadlubar FF (1986) The effects of saccharin on the development of neoplastic lesions initiated with N-methyl-N-nitrosourea in the rat urothelium. Fundam Appl Toxicol 7:585–600
144. WHO (2010) Exposure to cadmium: a major public health concern. World Health Organization. www.who.int/ipcs/features/cadmium.pdf. Accessed 1 May 2014
145. Wolf C, Strenziokb R, Kyriakopoulosa A (2009). Elevated MT-bound Cadmium concentrations in urine from bladder carcinoma patients, investigated by size exclusion chromatography-inductively coupled plasma mass spectrometry. Anal. Chim Acta, 12,631(2), 218-222
146. Wu X, Lin J, Grossman HB, Huang M, Gu J, Etzel CJ, Amos CI, Dinney CP, Spitz MR (2007) Projecting individualized probabilities of developing bladder cancer in white individuals. J Clin Onc 25(31):4974–4981
147. Zeegers MP, Tan FE, Dorant E, Van den Brandt PA (2000) The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 89:630–639
148. Zhou XD, Sens DA, Sens MA, Namburi VB, Singh RK, Garrett SH, Somji S (2006) Metallothionein-1 and -2 expression in cadmium- or arsenic-derived human malignant urothelial cells and tumor heterotransplants and as a prognostic indicator in human bladder cancer. Toxicol Sci 91(2):467–475